MTNB - Matinas BioPharma Holdings - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

Matinas BioPharma Holdings's activity chart (see below) currently has 9 price targets and 13 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 12.5% of the time, taking 69.75 days on average.

Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 31-Oct-2024. First documented stock forecast 21-Nov-2016.

Best performing analysts who are covering MTNB - Matinas BioPharma Holdings:

Edward Tenthoff Yasmeen Rahimi Jason Mccarthy Andrew Fein

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 21-Nov-2016

$250

2 years 21 days ago
(31-Oct-2024)

0/2 (0%)

$202.2 (423.01%)

Buy Since 26-Jun-2019

$150

3 years 9 months 21 days ago
(31-Jan-2023)

0/2 (0%)

$95.5 (175.23%)

Buy Since 25-Aug-2020

$90

5 years 6 months 10 days ago
(11-May-2021)

0/2 (0%)

$3 (3.45%)

Buy Since 27-Jan-2020

$75

$150

6 years 7 months 21 days ago
(31-Mar-2020)

1/2 (50%)

$45 (150.00%)

279

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MTNB (Matinas BioPharma Holdings) average time for price targets to be met?

On average it took 70 days for the stock forecasts to be reached, with an average price target met ratio of 12.5%.

Which analyst most recently updated their price target on MTNB (Matinas BioPharma Holdings)?

Jason Mccarthy

Which analyst has the lowest performance score on MTNB (Matinas BioPharma Holdings) with a proven track record?

ANDREW FEIN

Which analyst has the most public recommendations on MTNB (Matinas BioPharma Holdings)?

Jason Mccarthy works at MAXIM GROUP and has 3 price targets and 3 ratings on MTNB

Which analyst is the currently most bullish on MTNB (Matinas BioPharma Holdings)?

Edward Tenthoff with the highest potential upside of $73.81

Which analyst is the currently most reserved on MTNB (Matinas BioPharma Holdings)?

Andrew Fein with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?